Peetz Christopher reported option exercise involving 20,000 shares of Mirum Pharmaceuticals, Inc. at $2.94 for $58.7k on Nov 4, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CHIEF EXECUTIVE OFFICER
CHIEF EXECUTIVE OFFICER
Filed Nov 4, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$58,720Shares × reported price
Shares traded
20,000Common Stock
Price per share
$2.94Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
226,637Direct
Trade date
Nov 4, 2026Option exercise
Filed
Nov 4, 2026, 8:46 PM ET1-day reporting delay
Accession
0001614740-26-000015Code M · Transaction 393117
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Sell20,000$90.00−$1,800,000Trade 393118
Nov 4, 2026Option exercise20,000$0.00$0Trade 393119
3 transaction rows in this filing. Joint filers share the same rows.

MIRM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MIRM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −13%1w ago −8.3%1d ago −7%
Returns since7d +1.1%30d90d180d1y

Footnotes in full

F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F2: The stock option is fully vested.